Start for free
Start for free
Eshelman Ventures logo

Eshelman Ventures

North America, North Carolina, United States, Wilmington

Description

Eshelman Ventures, based in New Castle, provides investment to private healthcare companies.

Investor Profile

Eshelman Ventures has made 17 investments, with 1 in the past 12 months and 41% as lead.

Stage Focus

  • Series B (24%)
  • Series Unknown (24%)
  • Post Ipo Equity (18%)
  • Series C (12%)
  • Series A (12%)
  • Series D (6%)
  • Angel (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
  • Biopharma
  • Developer Platform
  • Clinical Trials
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eshelman Ventures frequently co-invest with?

Mountain Group Capital
Mountain Group Capital
North America, Tennessee, United States, Nashville
Co-Investments: 2
Hatteras Venture Partners
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 2
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
MedImmune Ventures
MedImmune Ventures
North America, Maryland, United States, Gaithersburg
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Lumira Ventures
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Aju IB Investment
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 1
Foresite Capital
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
Cowen Group
Cowen Group
North America, New York, United States, New York
Co-Investments: 1
Boxer Capital
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

Which angels does Eshelman Ventures often collaborate with?

TE
Terry Engle
North America, Colorado, United States, Fort Collins
Shared Deals: 1
YM
Yuri Milner
North America, California, United States, Los Altos Hills
Shared Deals: 1

What are some of recent deals done by Eshelman Ventures?

Jupiter BioVentures

Delaware City, Delaware, United States

Jupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects.

BiotechnologyTherapeutics
Series UnknownNov 19, 2024
Amount Raised: $70,000,000
Aravive Biologics

Houston, Texas, United States

Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways.

BiotechnologyClinical TrialsHealth Care
Post Ipo EquityOct 25, 2022
Amount Raised: $41,500,000
Sapience Therapeutics

Scarsdale, New York, United States

Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs

BiotechnologyMedicalTherapeutics
Series BMay 31, 2022
Amount Raised: $41,000,000
Incyclix Bio

Durham, North Carolina, United States

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BMar 31, 2022
Amount Raised: $30,000,000
Aravive Biologics

Houston, Texas, United States

Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways.

BiotechnologyClinical TrialsHealth Care
Post Ipo EquityJan 3, 2022
Amount Raised: $10,000,000
Incyclix Bio

Durham, North Carolina, United States

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series UnknownAug 6, 2020
Amount Raised: $6,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquityDec 26, 2019
Amount Raised: $22,400,000
Kinnate Biopharma

San Diego, California, United States

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.

BiopharmaBiotechnologyHealth CareMedicalOncologyTherapeutics
Series BDec 19, 2019
Amount Raised: $74,500,000
Aruna Biomedical

Athens, Georgia, United States

ArunA Biomedical is a research company that specializes in the fields of stem cells, neural stem cells, drug toxicity assay.

BiotechnologyMedicalMedical Device
Series UnknownJul 24, 2019
Amount Raised: $13,000,000
Kinnate Biopharma

San Diego, California, United States

Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.

BiopharmaBiotechnologyHealth CareMedicalOncologyTherapeutics
Series AApr 1, 2018
Amount Raised: $22,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator